EGFR and lung cancer: With the potential importance of ErbB receptor inhibitors for lung cancer treatment, and with multiple ErbB receptors activated in these cell lines, we investigated their sensitivity to the dual EGFR/Her2 kinase inhibitor GW2974 in proliferation assays.